Preferential Allotment/QIP
Wardwizard Healthcare Promoter Gets 42 Lakh Warrants
Wardwizard Healthcare disclosed promoter Yatin Sanjay Gupte’s preferential allotment of 42,00,000 fully convertible warrants at ₹10 each.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Bearish
0
Neutral
14
Bullish
0
Bearish
0
Neutral
46
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Bearish
0
Neutral
32
Bullish
0
Commercial Services & Supplies
Trading & Distributors
1 Cr
Low Risk
21.4
20.5
-0.2
—
45.34
41.14
Sales CAGR
Profit CAGR
ROE
ROCE
Preferential Allotment/QIP
Wardwizard Healthcare disclosed promoter Yatin Sanjay Gupte’s preferential allotment of 42,00,000 fully convertible warrants at ₹10 each.
Regulatory/Compliance Filing
Wardwizard Healthcare disclosed that non-promoter Aakanksha Kabra acquired 250,000 convertible securities, representing 2.25% of diluted voting capital.
Regulatory/Compliance Filing
Wardwizard Healthcare Ltd disclosed Arpit Kabra’s acquisition of 6,30,000 convertible securities representing 5.67% of diluted voting capital.
Preferential Allotment/QIP
Wardwizard Healthcare allotted 1.087 crore fully convertible warrants to promoter and non-promoter investors at ₹10 each, receiving ₹2.72 crore as the initial 25% subscription amount.
Financial Results
Wardwizard Healthcare published newspaper advertisements for its unaudited standalone financial results for the quarter and six months ended 30 September 2026.
Change in Directors/KMP
Wardwizard Healthcare appointed Ms. Diksha Sharma as an Additional Independent Woman Director for a five-year term effective 30 October 2026, subject to shareholder approval.
Wardwizard Healthcare Ltd (WARDHEALTH) is currently trading at 45.34 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Wardwizard Healthcare Limited (formerly Ayoki Merchantile Limited) is repositioning from trading and advisory services into the healthcare sector, having changed its name in December 2023 and declared intent to pursue hospital activities, healthcare services, medical education, pharmacies, ambulance and home care operations as part of a strategic shift under new promoters. Financially, the company reported steady standalone revenues of INR 531.22 for Q3 FY2026 and INR 1,882.27 for nine months ended December 31, 2025, generating modest profitability with nine-month PAT of INR 96.12 and basic diluted EPS of INR 1.79, indicating early-stage commercial activity with limited scale but positive operating margins. Auditor commentary highlights that the company did not carry out significant healthcare service activities during the quarter under review, and management is actively strategizing and evaluating the feasibility of planned healthcare operations, which signals the organisation remains in planning and early execution rather than full commercial rollout. The company experienced a substantial change of shareholding and control via the 2023-24 open offer, which materially altered ownership and strategic intent; Wardwizard Healthcare Limited is therefore in transition, with the new promoter group steering the move into capital-intensive healthcare verticals that will require clear execution and funding plans.
Over the past 52 weeks, Wardwizard Healthcare Ltd has traded between a low of ₹41.14 and a high of ₹45.34. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Wardwizard Healthcare Ltd has a market capitalization of approximately 1.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Wardwizard Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 21.39 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1.11 Cr, Wardwizard Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Wardwizard Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Wardwizard Healthcare Ltd is 21.39. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Wardwizard Healthcare allotted 42 lakh fully convertible warrants to Yatin Sanjay Gupte on November 4, 2026. Each warrant can convert into one fully paid-up equity share with a face value of Rs 10.
Wardwizard Healthcare allotted 1.087 crore fully convertible warrants on November 4, 2026. The instruments were allotted to 17 promoter and non-promoter investors at Rs 10 per warrant.
Wardwizard Healthcare Limited closed an issue of 10.87 million fully convertible warrants at ₹2.50 each. The stated gross proceeds were ₹2.7175 crore.
Wardwizard Healthcare reported profit after tax of Rs 21.95 lakh for the quarter ended September 30, 2026. It reported a Rs 26.02 lakh loss for the corresponding quarter in 2025. Total comprehensive income was Rs 21.09 lakh after a Rs 0.86 lakh other comprehensive loss.